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Abstract In order to investigate the mechanisms how modified 
lipoproteins enhance foam cell formation, we cultured peripheral 
blood monocytes with various stimulants and examined the 
effects of aggregated low-density lipoprotein (agLDL) on cell 
viability and lipid metabolism. AgLDL could completely inhibit 
phorbol ester-induced apoptosis, which was accompanied by 
intracellular cholesterol accumulation. Suppression of apoptosis-
promoting proteases, ICE and CPP32, was observed in agLDL-
treated cells. This indicates that agLDL accelerates foam cell 
formation through inhibition of apoptosis and enhancement of 
lipid accumulation in activated monocytes. By contrast, apopto-
sis was enhanced when monocytes were cultured with agLDL and 
M-CSF. Intracellular cholesterol accumulation was not signifi-
cant in M-CSF treated cells. This suggests that M-CSF may act 
anti-atherogenic through apoptotic elimination of lipid-baring 
macrophages and enhanced lipid turnover. Our observation 
supports the novel hypothesis that regulation of apoptosis may 
play an important role in the development of atherosclerosis. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Apoptosis is the cellular events of cell death that cause the 
elimination of certain stimulated cells to maintain tissue ho-
meostasis [1]. It occurs during differentiation of lymphocytes, 
granulocytes, and also of monocytes [2]. Although many num-
bers of monocytes are produced daily and released into the 
blood stream [3], most of them are programmed to die via 
apoptosis in the absence of certain stimuli [4]. Defects in the 
apoptotic program may result in pathologic states such as 
development of monocytic leukemia [5] and severe tissue dam-
age as observed in transgenic mice overexpressing granulo-
cyte-macrophage colony stimulating factor (GM-CSF) [6]. Re-
cently, it has been shown that several inflammatory cytokines 
such as interleukin-1 (IL-1) or IL-1 receptor antagonist are 
involved in the regulation of apoptosis of monocytes [4,5], and 
their down-stream effectors, including IL-1 converting enzyme 
(ICE) [7], CPP32 [8] and ICH-1 [9] were isolated. 
Monocytes are now believed to play a pivotal role in the 
development of atherosclerosis [10]. Patrolling monocytes ef-
fectively recruit from the circulation to local inflammatory 
sites and can attach to injured endothelium of vessel walls 
under the influence of chemoattractants. Then, these mono-
cytes migrate into the vessel walls and become macrophages if 
they can escape apoptotic cell death. Modified lipoproteins 
(oxidized LDL, acetyl LDL and aggregated LDL) are incor-
porated into macrophages and cause lipid accumulation [11]. 
This results in foam cell formation, which is a common fea-
ture of the earlier atherosclerotic lesion [12]. 
Although it is plausible that foam cell formation is regu-
lated by the apoptotic program, to our knowledge there is no 
direct evidence indicating the relationship between these two 
processes. Certain stimulants, such as phorbol esters or M-
CSF, have been shown to regulate both apoptosis [13] and 
lipid accumulation [14]. Therefore, using these reagents, it is 
possible to investigate how apoptosis is connected to intra-
cellular lipid accumulation of monocytes leading to athero-
sclerosis. 
Recently, several enzymes that mediate intracellular lipid 
metabolism have been characterized. Lysosomal acidic choles-
teryl ester hydrolase (ACEH) releases free cholesterol (FC) 
from cholesteryl ester (CE) of incorporated lipoproteins [15]. 
Acyl-coenzyme A: cholesterol acyltransferase (ACAT) acts in 
cytoplasm and re-synthesizes CE from the released FC, and 
neutral CE hydrolase (NCEH) degrades accumulated CE in 
cytoplasm [16]. These enzymes play some roles in intracellular 
accumulation of CE, and are shown to be regulated by M-
CSF during monocytic differentiation [17]. Recent investiga-
tions revealed that estradiol could increase NCEH activity in 
human monocytes, which may contribute to anti-atherogenic 
properties of the female gender [18]. Although the nature of 
NCEH is not fully understood, NCEH and hormone-sensitive 
lipase (HSL) are suspected to be the products of a single gene 
in macrophage [19]. 
In this study, we investigated the effects of agLDL on apop-
tosis of phorbol ester- or M-CSF-stimulated monocytes. We 
also examined the changes in expression of the molecules that 
modulate apoptosis (IL-lß, ICE, CPP32 and ICH-1) and lipid 
metabolism (ACEH, ACAT and HSL) in order to know how 
apoptotic events and cholesterol accumulation are interrelated 
and implicated in the development of atherosclerosis. 
2. Materials and methods 
2.1. Reagents 
All chemicals including phorbol 12-myristate 13-acetate (PMA) 
were obtained from Sigma Chemical Co. (St. Louis, MO) unless 
stated otherwise and were of the highest purity available. Recombi-
nant human M-CSF with a specific activity of 2xl05 U/mg was 
provided by Morinaga Milk Industry Co. Ltd. (Tokyo, Japan). 
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2.2. Preparation of LDL 
LDL was isolated from the serum of normolipidemic donors by 
sequential ultracentrifugation at densities between 1.006 and 1.065 
g/ml in a ultracentrifuge (model CP100-a, Hitachi Koki Co., Ibaraki, 
Japan) and was dialyzed at 4°C against phosphate buffer solution 
(PBS; pH 7.5) [20]. Aggregated LDL was made by vortexing for 60 
s in Eppendorf tubes as previously described [21]. 
2.3. Isolation of monocytes and culture 
Normal human monocytes were isolated from the peripheral blood 
of healthy volunteers by counterflow centrifugal elutriation (SRR6Y 
elutriation system, Hitachi Koki Co. Ltd., Ibaraki, Japan) as de-
scribed elsewhere [22], Monocyte-enriched fractions ( > 90% purity) 
were resuspended at 3X106 cells/ml in Dulbecco's modified Eagle's 
medium (Life Technologies Inc., Grand Island, NY) and cultured 
in the presence of autologous serum (0.2%). Where indicated, PMA 
and M-CSF were added at the final concentration of 10 ng/ml and 
50 ng/ml, respectively, which was determined as optimal in pilot ex-
periments. 
2.4. Assessment of apoptosis 
The proportion of apoptotic cells was quantified by flow cytometric 
analysis and DNA electrophoresis as previously described [23]. The 
percentage of subdiploid fractions was calculated using FACScan/ 
CellFIT system (Becton-Dickinson, San Jose, CA). 
2.5. Semiquantitative reverse transcription-polymerase chain reaction 
(RT-PCR) 
RT-PCR analysis was carried out as previously described [23]. To-
tal cellular RNA from 1 X105 cells was reverse transcribed into cDNA 
and amplified by PCR for 35 cycles with the following primer pairs 
(predicted molecular sizes are shown in parentheses): IL-lß, (1) 5'-
CTTCATCTTTGAAGAAGAACCTATCTTCTT-3' and (2) 5'-AA-
TTTTTGGGATCTACACTCTCTCCAGCTGTA-3' (323 bp) [24]; 
ICE, (1) 5'-AGGACAACCCAGCTATGCCCACAT-3' and (2) 5'-
CTTCGGTTTGTCCTTCAAACTT-3' (483 bp) [7]; CPP32, (1) 5'-
CTCAGTGGATTCAAAATCCAT-3' and (2) 5'-CTGTCTGTCTC-
AATGCCACAG-3' (510 bp) [8]; ICH-1, (1) 5'-CCAGCTGGCATA-
TAGGTTGCAGT-3' and (2) 5'-TCAACCCCAAGATCAGTCTCA-
3' (488 bp) [9]; ACAT, (1) 5'-GAGGAAGATGAAGACCAGA-
GAAAC-3' and (2) 5'-TGTTCTGATGAGGTCCAGTTCAAG-3' 
(359 bp) [25]; ACEH, (1) 5'-ACAGATCCCTGAGCTGGCTA-3' 
and (2) 5'-TCCAGACTGCAGTCGGCACA-3' (467 bp) [15]; HSL, 
(1) 5'-GCCAGAAAAGACACCCATAGCCCA-3' and (2) 5'-GC-
CAGCATTGAGACAAAGACATGT-3' (324 bp) [26]; GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase), (1) 5'-CCACCCATGG-
CAAATTCCATGGCA-3' and (2) 5'-TCTAGACGGCAGGTCAG-
GTCCACC-3' (600 bp) [27]. 
2.6. Measurement of intracellular cholesterol 
Cells were washed 3 times with PBS, and were dissolved in PBS 
Fig. 1. Effects of agLDL on apoptosis and expression of apoptosis-related genes in monocytes. Human peripheral blood monocytes were cul-
tured with no stimulants, 10 ng/ml of PMA or 50 ng/ml of M-CSF in the absence (None, PMA and M-CSF) or presence of agLDL (+LDL). 
A: DNA was isolated after 48 h and subjected to agarose gel electrophoresis. B: RNA was isolated after 12 h and subjected to semiquantita-
tive RT-PCR analysis for IL-lß, ICE, CPP32, ICH-1 and GAPDH mRNA expression. Bio Marker Low (Bio Ventures, Inc., Murfreesboro, 
TN) was used as a molecular size marker (marker). 
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containing Triton-X (0.3%) and cholic acid (0.3%). Thereafter, cho-
lesterol concentration of the solution was measured according to the 
standard method using cholesterol oxidase with minor modifications 
[28]. Cholesteryl ester hydrolase was included in the reaction mixture 
for the determination of total cholesterol (TC). Free cholesterol (FC) 
level was determined in the assay without cholesteryl ester hydrolase. 
Cholesteryl ester concentration was calculated as TC minus FC. 
2.7. Other assays 
Protein concentration was measured by the microprotein assay 
(BioRad Co., Richmond, CA) with bovine serum albumin as a stand-
ard. Oil red staining was performed with 3 mg/ml of oil red in 60% 
ethanol as described previously [11]. All experiments were carried out 
for a minimum of 3 times in triplicate or quadtriplicate. Results were 
expressed as mean ± SD and statistically evaluated by paired Student's 
/-test. 
3. Results 
3.1. Effects of aggregated LDL on apoptosis of monocytes 
Human peripheral blood monocytes were isolated in a nas-
cent state by centrifugal elutriation, and cultured in the ab-
sence or presence of various stimulants. After 48 h of the 
culture, the cells were harvested for the evaluation of apopto-
sis by flow cytometry and DNA electrophoresis. When mono-
cytes were cultured without any stimulants, subdiploid DNA 
fractions, which correspond to DNA fragmentation, were ob-
served in approximately 25% of the cells on propidium iodide 
staining. Consistent with the result of flow cytometric analy-
sis, agarose gel electrophoresis revealed moderate level of oli-
Fig. 2. Lipid accumulation in unstimulated and stimulated monocytes. Monocytes were cultured with various stimulants as described in Fig. 1 
legend. A: The cells were harvested after 48 h, and subjected to oil red staining on cytospin slides. Original magnification: X400. B: Intracellu-
lar cholesterol (TC; total cholesterol, CE; cholesteryl ester) was measured by the enzyme-based assay methods. Mean±SD (bar) of three inde-
pendent experiments was shown. 
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Fig. 3. Expression of the genes involved in lipid metabolism during 
foam cell formation. Total cellular RNA was isolated as described 
in Fig. 1 legend, and expression of ACAT, ACEH, HSL and 
GAPDH mRNAs was examined by semiquantitative RT-PCR ac-
cording to the standard method. Bio Marker Low was used as a 
molecular size marker (marker). 
gonucleosomal-length DNA fragmentation (Fig. 1A, None). 
Activation of monocytes with PMA resulted in marked en-
hancement of apoptosis, i.e. the proportion of subdiploid frac-
tions was increased to 46 ± 8% and DNA fragmentation was 
significantly enhanced (Fig. 1A, PMA). In contrast, M-CSF 
could inhibit spontaneous apoptosis of monocytes as indi-
cated by the disappearance of DNA fragmentation (Fig. 1A, 
M-CSF). The percentage of subdiploid fractions was also de-
creased to 19 ±7% after 48 h of the culture with M-CSF. 
With this culture system, we investigated the effects of 
agLDL on apoptosis of activated and non-activated mono-
cytes. AgLDL did not affect spontaneous apoptosis of mono-
cytes at the concentrations between 0.1 and 1.0 mg/ml (the 
result with 0.5 mg/ml was shown in Fig. 1A, None+LDL). On 
the other hand, agLDL could inhibit PMA-induced apoptosis 
of monocytes. DNA fragmentation was almost completely 
suppressed by the addition of agLDL (Fig. 1A, PMA+LDL) 
and the proportion of subdiploid fractions was reduced to 
30 ± 17% (P<0.05 vs. PMA alone). On the contrary, the in-
hibitory effect of M-CSF on apoptosis was abrogated by 
agLDL. AgLDL induced typical DNA ladder in M-CSF-
treated monocytes (Fig. 1A, M-CSF+LDL) and increased 
the percentage of subdiploid fractions to 26 ±2% (i* < 0.05 
vs. M-CSF alone) on flow cytometric analysis. 
3.2. Expression of apoptosis-related genes in monocytes treated 
with agLDL 
To elucidate the mechanisms how LDL modulates apopto-
sis of activated monocytes, we investigated expression of some 
apoptosis-related genes (IL-lß, ICE, CPP32 and ICH-1) by 
semiquantitative RT-PCR. We chose this method because 
only relatively small amounts of RNA could be obtained 
from dying cells, and many genes including a ubiquitously 
expressed control (GAPDH in this study) could be detected 
simultaneously in the same sample [23]. Any apoptosis-related 
gene was not expressed in monocytes just after the isolation, 
whereas GAPDH mRNA was readily detectable (data not 
shown). Fig. IB shows the representative result with samples 
isolated after 12 h of the culture. In consistent with the in-
duction of spontaneous apoptosis, ICE, CPP32 and ICH-1 
mRNA transcripts, which encode cysteine proteases with 
properties of mediating apoptosis, were induced during cul-
ture without any stimulants (Fig. IB, None). Increased ex-
pression of IL-lß, which acts on monocytes to prevent apop-
tosis [4,5], was also observed. AgLDL did not affect 
expression of these genes in unstimulated monocytes (Fig. 
IB, None+LDL). In contrast, both CPP32 and ICE mRNAs 
were up-regulated in PMA-activated monocytes, whereas IL-
lß expression was remarkably suppressed (Fig. IB, PMA). 
This imbalance between apoptosis inducer (CPP32, ICE) 
and protector (IL-lß) may at least in part contribute to 
marked enhancement of apoptosis in PMA-treated cells. 
AgLDL could dramatically modulate the effects of PMA on 
expression of these genes, i.e. the amounts of CPP32 and ICE 
mRNA transcripts were significantly decreased in cells treated 
with PMA and agLDL (Fig. IB, PMA+LDL). Similarly, 
PMA-induced suppression of IL-lß was reversed by the addi-
tion of agLDL. These changes may explain why agLDL can 
suppress PMA-induced apoptosis. M-CSF did not modulate 
the expression of these genes, suggesting that its anti-apop-
totic effects might be mediated through distinct mechanisms. 
However, agLDL could significantly increase CPP32 mRNA 
expression and also decreased IL-lß mRNA expression in 
M-CSF-treated monocytes (Fig. IB, M-CSF+LDL). This is 
compatible with apoptosis-inducing properties of agLDL in 
M-CSF-treated cells. Expression of ICH-1 and GAPDH, an 
internal control, was stable in these samples. 
3.3. Lipid accumulation in agLDL-treated monocytes 
Next, we examined the levels of intracellular lipid accumu-
lation in monocytes cultured with agLDL in the absence or 
presence of the stimulants (PMA or M-CSF). After 48 h of 
the culture, cells were stained with oil red on cytospin speci-
mens. As shown in Fig. 2A, lipid accumulation was most 
striking in monocytes cultured with PMA (PMA+LDL). It 
was weak in M-CSF-treated cells (M-CSF+LDL). No signifi-
cant staining was observed in those cultured with agLDL 
alone (None+LDL). Then, intracellular cholesterol levels 
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were determined by enzyme-based assay methods (Fig. 2B). 
The amount of total cholesterol (TC) in cells treated with 
PMA and LDL was significantly higher than that of agLDL 
alone (70.9 ± 14.7 mg/mg protein vs. 37.6 ± 5.8 mg/mg protein, 
P < 0.05). In contrast, the difference in TC levels between cells 
stimulated with M-CSF+agLDL and those with agLDL alone 
was not significant (42.7 ±1.3 mg/mg cell protein vs. 37.6 ± 5.8 
mg/mg cell protein, i>>0.05). The pattern of intracellular 
cholesteryl ester (CE) accumulation was similar to that of 
TC, i.e., PMA+LDL (28.2 ±9.4 mg/mg cell protein) but not 
M-CSF+LDL (14.8 ± 3.9 mg/mg cell protein) showed a signif-
icant level of deposits as compared to agLDL alone (10.1 ±4.5 
mg/mg cell protein). Either PMA alone or M-CSF alone could 
not enhance the accumulation of intracellular TC and CE 
(data not shown). 
3.4. Expression of the genes involved in lipid metabolism 
(ACAT, ACEH and HSL) in monocytes during foam cell 
formation 
In an attempt to clarify the mechanisms of intracellular 
cholesterol accumulation during foam cell formation, we car-
ried out RT-PCR analysis for some genes involved in lipid 
metabolism (ACAT, ACEH and HSL) using RNA from 
monocytes cultured as described above. As depicted in Fig. 
3, ACAT mRNA was apparently up-regulated by M-CSF in 
the presence of agLDL, whereas it was not changed by other 
stimulants such as agLDL alone or PMA+agLDL. On the 
other hand, expression of ACEH and HSL mRNA transcripts 
was constitutive as compared to that of GAPDH, and unaf-
fected by any stimulants tested (Fig. 3). 
4. Discussion 
In this study, we investigated the role of apoptosis in foam 
cell formation from activated monocytes. First, in order to 
examine how modified lipoproteins modulate apoptotic cell 
death, we exposed human peripheral blood monocytes to ag-
gregated LDL in the absence or presence of various stimulants 
such as PMA and M-CSF. Activation of monocytes with 
PMA resulted in massive apoptotic cell death as recently re-
ported [13]. When agLDL was added to the culture with 
PMA, apoptosis was almost completely inhibited, which was 
accompanied by intracellular cholesterol accumulation. This 
suggests that inhibitory effect of agLDL on activation-induced 
apoptosis may contribute to differentiation of monocytes into 
macrophages and subsequent foam cell formation. 
When monocytes were cultured with M-CSF, spontaneous 
cell death was significantly inhibited in consistent with the 
previous observation [29]. Interestingly, the addition of 
agLDL reversed anti-apoptotic effect of M-CSF, suggesting 
that M-CSF, as opposed to PMA, could prevent foam cell 
formation of monocytes through induction of apoptosis. In 
addition, intracellular cholesterol was not significantly accu-
mulated in M-CSF-treated cells. It has been reported that 
M-CSF stimulates the clearance of lipoproteins in rabbits 
[30]. It also stimulates the uptake and degradation of acetyl-
ated LDL, cholesterol esterification, and cholesterol efflux in 
human macrophages [17]. In sum, this cytokine is thought to 
possess protective effects against atherosclerosis. Our present 
finding is in line with these observations, and provides the first 
evidence that M-CSF may also act anti-atherogenic through 
the elimination of lipid-baring macrophages by apoptosis. 
Recent investigation demonstrated that execution of apop-
totic process involves redundant activation of several pro-
teases [31]. These proteases are considered to be mammalian 
homologs of ced-3 of Caenorhabditis elegans, and share a 
common sequence, QACRG, which contains the active-site 
cysteine. They are now subdivided into three groups (ICE-, 
CPP32- and ICH-1-related protease family) and functional 
analysis, including identification of their substrates, are being 
progressed [31]. In this study, we examined the expression of 
these apoptosis-promoting proteases during foam cell forma-
tion of monocytes, and found that levels of ICE and CPP32 
but not ICH-1 were dramatically changed in accordance with 
the modulation of apoptosis by agLDL. Given that activation 
of these proteases is regulated by extracellular signals such as 
Fas [32], it is likely that LDL can also directly modify the 
expression of these molecules. It seems interesting to investi-
gate its signaling pathways in LDL-treated macrophages. In 
this context, it is of note that CPP32 may participate in up-
regulation of sterol import by activating sterol response ele-
ment-binding proteins to induce transcription of genes in-
volved in sterol metabolism [33]. This suggests that, in concert 
with our findings, CPP32 is a key molecule to further clarify 
the relationship between apoptosis and lipid accumulation 
during development of atherosclerosis. 
In addition, we found that IL-lß mRNA expression was 
also regulated by agLDL in activated monocytes. Since IL-
lß is known to suppress apoptosis of monocytes [4] and is a 
major substrate of ICE [7], the balance between IL-lß and 
ICE-like proteases may also be a determinant of cell fate. 
Indeed, relative increase in IL-lß over ICE was observed 
when apoptosis was suppressed in PMA-activated monocytes 
by agLDL, and vice versa in cells treated with M-CSF and 
agLDL. Moreover, agLDL-induced IL-lß production may 
also contribute to the formation of atherosclerotic lesions, 
since IL-lß promotes proliferation of smooth muscle cells 
[10]. 
Accumulation of CE in PMA/agLDL-stimulated cells could 
not be explained by the changes in specific gene expression. 
For example, PMA-induced increase of ACAT was abrogated 
in the presence of agLDL. Furthermore, the amounts of 
ACEH and HSL were comparable between cells stimulated 
by PMA alone and those with PMA and agLDL. Therefore, 
down-regulation of NCEH activity, other than HSL, may be 
responsible for lipid accumulation during foam cell formation. 
Previous study demonstrated that M-CSF could increase 
NCEH activity in cultured macrophages, suggesting that 
NCEH is also important for M-CSF to act anti-atherogenic 
[14]. Further characterization of the NCEH activity is re-
quired for better understanding of the mechanisms of foam 
cell formation. 
In summary, our observation supports novel hypothesis 
that inhibition of apoptotic elimination of lipid-baring macro-
phages by modified lipoproteins, along with enhanced lipid 
accumulation, may contribute to the development of athero-
sclerosis. 
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